E. Shi

Blood‐based detection of <i><scp>RAS</scp></i> mutations to guide anti‐<scp>EGFR</scp> therapy in colorectal cancer patients: concordance of results from circulating tumor <scp>DNA</scp> and tissue‐based <i><scp>RAS</scp></i> testing

Wolff Schmiegel, Rodney J. Scott, S Dooley et al. · Molecular Oncology · 2017 · 159 citations · Full text

Cigarette Smoking, Genetic Variants in Carcinogen-metabolizing Enzymes, and Colorectal Cancer Risk

Sean P. Cleary, Michelle Cotterchio, E. Shi et al. · American Journal of Epidemiology · 2010 · 95 citations · Full text

Genetics, Epidemiology Of Cancer, Genetic Epidemiology +18

Relationships between age and epi-genotype of the FMR1 exon 1/intron 1 boundary are consistent with non-random X-chromosome inactivation in FM individuals, with the selection for the unmethylated state being most significant between birth and puberty

David E. Godler, Y. Inaba, E. Shi et al. · Human Molecular Genetics · 2013 · 22 citations · Full text

Fragile X–related element 2 methylation analysis may provide a suitable option for inclusion of fragile X syndrome and/or sex chromosome aneuploidy into newborn screening: a technical validation study

Yoshimi Inaba, Amy S. Herlihy, Charles E. Schwartz et al. · Genetics in Medicine · 2012 · 20 citations · Full text

Genetic Testing, Element 2, Genetic Disorder +11